tretinoin and Critical-Illness

tretinoin has been researched along with Critical-Illness* in 3 studies

Other Studies

3 other study(ies) available for tretinoin and Critical-Illness

ArticleYear
Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia.
    European journal of haematology, 2004, Volume: 72, Issue:6

    Topics: Adult; Catheterization, Central Venous; Critical Illness; Factor VII; Factor VIIa; Female; Femoral Artery; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Recombinant Proteins; Transfusion Reaction; Tretinoin

2004
All-trans retinoic acid and short-time, high-dose cytarabine in two children with acute promyelocytic leukemia.
    Medical and pediatric oncology, 1996, Volume: 26, Issue:4

    We report on two girls, 3 and 13 years old, with acute promyelocytic leukemia (APL) who were successfully treated with all-trans retinoic acid (ATRA) 45 mg/m2/day. "Retinoic acid syndrome" was prevented with short-time treatment of high dose (4 x 1.5 g/m2) cytarabine. This regimen was well tolerated, although both children were critically ill. They achieved a complete remission confirmed by light microscopy, but reverse transcriptase polymerase chain reaction remained positive after ATRA, underlining the need of further chemotherapy.

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents; Child, Preschool; Critical Illness; Cytarabine; Female; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Remission Induction; Syndrome; Tretinoin

1996
ATRA administration in the critically ill patient.
    Leukemia, 1995, Volume: 9, Issue:7

    Topics: Child; Critical Illness; Humans; Intubation, Gastrointestinal; Leukemia, Promyelocytic, Acute; Male; Solvents; Soybean Oil; Tretinoin

1995